Stage II and III Colon Cancer Patients Sought for Interviews

Posted by Kate Murphy on July 18th, 2008
Tags: clinical trials, patient education

Research to Practice, a medical and patient education group, is looking for patients who have been recently diagnosed with either stage II or III colon cancer and are either receiving chemotherapy for their cancer or deciding whether or not to have chemotherapy.

Patient surveys will be used to understand patient perspectives as they make treatment decisions about chemotherapy after surgery and their experiences throughout chemotherapy and afterwards.  Information will be analyzed and presented to health professionals who work with colon cancer patients.

In addition, patients will provide their opinions about educational materials being developed to help patients make treatment decisions and manage chemotherapy.

In order to be part of the program, patients must:

As part of the program, participants will be asked to finish:

Participants will receive a stipend of up to $250.

For more information, or to register:

Information will be kept confidential and no names will connected to individual replies.  Names and addresses are necessary only to receive the stipend, and patients who wish to be completely anonymous can donate their stipend to a charity they choose.

More information about Research to Practice.

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions.

C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond where appropriate.

For the best response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe